Cinaport to Adjourn Annual General and Special Meeting of Shareholders to December 20, 2018
Toronto, Ontario–(Newsfile Corp. – December 3, 2018) – Cinaport Acquisition Corp. II (TSXV:CPQ.P) (“Cinaport” or the “Company“), a capital pool company listed on the TSX Venture Exchange (the “Exchange“), today announces that it intends to ... [Read]
Aura Provides Update on the 2018 Greyhound Exploration Program
Ottawa, Ontario–(Newsfile Corp. – December 3, 2018) – Aura Resources Inc. (TSXV:AUU) (“Aura” or the “Company”) wishes to provide an update on its exploration program on the Greyhound project, a partnership with Agnico Eagle Mines ... [Read]
CannabisNewsAudio Announces Audio Press Release (APR) on Chemistree Technology, Inc.’s Strategic Move Into California Represents Big Cannabis Advantage
NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) — via CannabisNewsWire – CannabisNewsAudio announces the Audio Press Release (APR) titled “Change in Attorney General Could Mean a Cannabis Revolution in the US,” featuring Chemistree Technology Inc. (CSE:CHM, OTCQB:CHMJF, FRA: ... [Read]
Avino Announces Further Extension of Concentrates Prepayment Agreement with Samsung C&T
Canada NewsWire VANCOUVER, Nov. 30, 2018 VANCOUVER, Nov. 30, 2018 /CNW/ – Avino Silver & Gold Mines Ltd. (ASM:TSX/NYSE American, GV6: FSE, “Avino” or “the Company”) is pleased to announce that the concentrates prepayment agreement with Samsung C&T U.K. ... [Read]
Theralase’s Rutherrin(R) Photo Dynamic Therapy Induces Immune Response to Destroy Human Brain Cancer Cells
Rutherrin® mediated Photo Dynamic Therapy improves cancer specific immune responses by switching the so called “Don’t eat me” signal that cancer cells use to trick the immune system into the “Eat me” signal on treated human ... [Read]
IBC Advanced Alloys Reports Fiscal Q1 2019 Financial Results
Highlights of the Quarter (unless other noted, all financial amounts in this news release are expressed in U.S. dollars) Higher Y/Y Sales: Sales revenue rose 9.3% to $4.7 million, ... [Read]
Emerald Health Therapeutics Reports 3rd Quarter 2018 Financial Results and Provides Corporate Update
VICTORIA, British Columbia, Nov. 30, 2018 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald” or “the Company”) has filed its financial statements and management discussion and analysis for the three and nine months ... [Read]
Antibe Therapeutics to Present at the 11th Annual LD Micro Main Event on December 4, 2018
Antibe Therapeutics to Present at the 11th Annual LD Micro Main Event on December 4, 2018 Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSXV:ATE, OTCQB:ATBPF), a leader in developing safer therapeutics for pain and inflammation, ... [Read]
Eloro Resources Announces Financing
TORONTO, Nov. 30, 2018 (GLOBE NEWSWIRE) — Eloro Resources Ltd. (TSXV:ELO; FSE: P2Q) (“Eloro” or the “Corporation”) is pleased to announce that it is proceeding with a non-brokered private placement (the “Private Placement”) of up ... [Read]
VIVO Cannabis™ Reports Record Revenue for Q3 2018
Revenue of $2.3 million Pro-Forma Revenue of $4.4 million NAPANEE, Ontario, Nov. 30, 2018 (GLOBE NEWSWIRE) — VIVO Cannabis Inc. (TSXV:VIVO, OTCQX:VVCIF) (“VIVO” or the “Company”), a licensed producer of cannabis under the Cannabis Act ... [Read]